Industry Reports

Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding Special Items, 2014 Second-Quarter EPS of $1.66 increased 12.2%* Johnson & Johnson today announced sales of $19.5 billion for the second...

Pivotal Therapeutics Inc. , a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2014.  All dollar amounts referenced...

China Nepstar Chain Drugstore Ltd., a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2014. Financial Highlights...

Can-Fite BioPharma Ltd. , a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported financial results for the first quarter ended March 31, 2014. Dr. Pnina Fishman,...

Adocia announces today its annual financial results for 2013. The financial statements were approved by the board of directors on March 21, 2014 and will be submitted to the shareholders for approval during the next general meeting on June...

Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic molecules, in particular proteins and oncologic drugs, announces today its revenue for the last quarter 2013 and full year end. ...

Bristol-Myers Squibb Company (NYSE:BMY) has reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company's announcement to sell its diabetes business as part of the continued evolution of its successful...